Alan O’Connell is a Partner of Seroba Kernel Life Sciences Limited. He has a background in product development and commercialization in the pharmaceutical and biotechnology industries. Alan currently sits on the boards of Diabetica, Crescent Diagnostics and Biosensia.. Prior to joining Seroba in 2003, Alan worked in a variety of product development. and business development roles at Elan Corporation (Dublin), American Biogenetic Sciences, Inc. (New York), and the Medicines Control Agency (London). His previous venture capital experience was gained at Estée Lauder Investments (New York) and he still sits on the Lauder Scientific Advisory Board.
